Status: Recruiting
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
This study aims to evaluate the efficacy of Adebrelimab plus concurrent chemoradiotherapy compared with placebo plus concurrent chemoradiotherapy for the treatment of locally advanced cervical cancer by evaluating progression-free survival (PFS).
Participants needed: 720
Trial details
Phase: Phase 3Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Shanghai Shengdi Pharmaceutical Co., LtdUpdated: Apr 15, 2026Locations: 1
Eligibility criteria
Participate in the study voluntarily, sign the informed consent form. [+5]
Pathologically or radiologically confirmed presence of distant metastatic diseas... [+7]